Department of Health and Human Services December 10, 2020 – Federal Register Recent Federal Regulation Documents

Proposed Collection; 60-Day Comment Request; CareerTrac
Document Number: 2020-27184
Type: Notice
Date: 2020-12-10
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institutes of Health Fogarty International Center (FIC), National Institute of Environmental Health Sciences (NIEHS), including the Superfund Research Program (SRP) within NIEHS, and National Cancer Institute (NCI), will publish periodic summaries of propose projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings
Document Number: 2020-27183
Type: Notice
Date: 2020-12-10
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2020-27182
Type: Notice
Date: 2020-12-10
Agency: Department of Health and Human Services, National Institutes of Health
Food and Drug Administration Fiscal Year 2020 Performance Review Board
Document Number: 2020-27123
Type: Notice
Date: 2020-12-10
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the names of the members who will serve on its fiscal year (FY) 2020 Performance Review Board (PRB). The purpose of the PRB is to provide fair and impartial review of Senior Executive Service (SES), Senior Professional, 21st Century Cures Act, and Title 42(f) (SES Equivalents) performance appraisals, bonus recommendations, and pay adjustments.
Allergan Pharmaceuticals International, Ltd.; Withdrawal of Approval of a New Drug Application for ASACOL (Mesalamine) Delayed-Release Tablets, 400 Milligrams
Document Number: 2020-27082
Type: Notice
Date: 2020-12-10
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is withdrawing the approval of the new drug application (NDA) for ASACOL (mesalamine) delayed-release tablets, 400 milligrams (mg), held by Allergan Pharmaceuticals International, Ltd., c/o Allergan Sales, LLC, 2525 Dupont Dr., Irvine, CA 92612 (Allergan). Pursuant to FDA's request, Allergan agreed to withdrawal of this application and has waived its opportunity for a hearing.
Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Health Clinic COVID-19 Testing Program Data Collection, OMB No. 0906-0056 − Extension
Document Number: 2020-27063
Type: Notice
Date: 2020-12-10
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate or any other aspect of the ICR.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.